MiMedx Group reported Q1 2025 revenue of $88.2M (+4.1% YoY), beat analyst consensus of $86.3M by $1.9M. Diluted EPS came in at $0.06 (-14.3% YoY).
Trailing eight quarters through Q1 2025
Common questions about MiMedx Group's Q1 2025 earnings report.
MiMedx Group (MDXG) reported Q1 2025 earnings on April 30, 2025 after market close.
MiMedx Group reported revenue of $88.2M and diluted EPS of $0.06 for Q1 2025.
Revenue beat the consensus estimate of $86.3M by $1.9M. EPS beat the consensus estimate of $0.06 by $0.00.
Compared to the same quarter a year prior, revenue grew 4.1% from $84.7M a year earlier and diluted EPS declined 14.3% from $0.07.
You can read the 10-Q periodic report (0001376339-25-000045) directly on SEC EDGAR. The filing index links above go to sec.gov.